Welcome to our dedicated page for W.R Berkley SEC filings (Ticker: WRB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating W.R. Berkley’s reserve development tables or the latest combined ratio buried deep in a 250-page annual report can be daunting. Add dozens of subsidiaries and suddenly tracking every Form 4 trade feels impossible. If you have ever typed “Where can I find W.R. Berkley’s quarterly earnings report?” you know the frustration.
Stock Titan solves this. Our platform delivers AI-powered summaries of every document, turning labyrinthine disclosures into clear insights. Need the W.R. Berkley annual report 10-K simplified? One click. Want a concise view of catastrophe losses from the most recent W.R. Berkley quarterly earnings report 10-Q filing? Already highlighted. We monitor the EDGAR feed continuously so W.R. Berkley Form 4 insider transactions real-time appear on your dashboard seconds after executives file.
- Instant alerts on W.R. Berkley insider trading Form 4 transactions and other executive stock moves
- Side-by-side W.R. Berkley earnings report filing analysis for trend comparison
- Plain-English explanations for every 8-K so W.R. Berkley 8-K material events explained actually means explained
- Quick access to the W.R. Berkley proxy statement executive compensation sections investors question most
Whether you’re understanding W.R. Berkley SEC documents with AI for the first time, or back-testing loss-ratio shifts, our coverage of all filings—10-K, 10-Q, 8-K, Form 4, DEF 14A—equips you to make informed decisions without wading through insurance jargon. Complex filings, clarified.
ANI Pharmaceuticals (ANIP) – Form 4 filing, 21 Jul 2025. Sr. VP, General Counsel & Secretary Meredith W. Cook reported a tax-related share withholding transaction on 18 Jul 2025.
- Transaction type: Code F (shares withheld to satisfy taxes on vested restricted stock).
- Securities affected: 2,071 common shares at an implied price of $66.30, total ≈ $0.14 million.
- Post-transaction holding: Cook now directly owns 76,874 common shares.
- Derivative positions: No derivative transactions reported; prior option/RSU holdings unchanged.
The filing reflects routine tax withholding rather than an open-market sale. Cook retains >97% of her pre-vesting equity stake, signalling continued alignment with shareholders. No impact on the company’s operations, earnings outlook or governance structure was disclosed.